CD28 and neoplasm: Tumor-derived Jurkat T cells preactivated with anti-CD2/CD3/CD28 antibodies strongly responded to the micro-arc CaP coating and showed a 4.5-fold upregulation of hTERT gene expression after 14-day culture (Table 2).